PROTEOSTASIS THERAPEUTICS IN's ticker is PTI and the CUSIP is 74373B109. A total of 42 filers reported holding PROTEOSTASIS THERAPEUTICS IN in Q3 2020. The put-call ratio across all filers is 1.44 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $363,000 | -19.7% | 330,586 | 0.0% | 0.00% | – |
| Q2 2020 | $452,000 | +20.2% | 330,586 | 0.0% | 0.00% | – |
| Q1 2020 | $376,000 | -80.1% | 330,586 | -60.1% | 0.00% | – |
| Q4 2019 | $1,890,000 | +444.7% | 829,438 | +101.6% | 0.00% | – |
| Q3 2019 | $347,000 | -14.7% | 411,468 | -1.4% | 0.00% | – |
| Q2 2019 | $407,000 | -29.9% | 417,176 | -9.6% | 0.00% | – |
| Q1 2019 | $581,000 | -78.7% | 461,336 | -45.2% | 0.00% | – |
| Q4 2018 | $2,728,000 | +340.0% | 842,070 | +226.9% | 0.00% | – |
| Q3 2018 | $620,000 | -4.6% | 257,590 | +10.5% | 0.00% | – |
| Q2 2018 | $650,000 | -18.5% | 233,193 | +38.7% | 0.00% | – |
| Q1 2018 | $798,000 | +96.1% | 168,141 | +140.3% | 0.00% | – |
| Q4 2017 | $407,000 | +154.4% | 69,976 | -8.3% | 0.00% | – |
| Q3 2017 | $160,000 | -55.2% | 76,292 | 0.0% | 0.00% | – |
| Q2 2017 | $357,000 | -50.3% | 76,292 | -17.0% | 0.00% | – |
| Q1 2017 | $718,000 | -34.6% | 91,936 | +2.6% | 0.00% | -100.0% |
| Q4 2016 | $1,098,000 | +37.2% | 89,565 | +74.4% | 0.00% | – |
| Q3 2016 | $800,000 | +37.7% | 51,358 | +7.1% | 0.00% | – |
| Q2 2016 | $581,000 | +41.0% | 47,955 | +12.1% | 0.00% | – |
| Q1 2016 | $412,000 | – | 42,777 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|